Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.1785
Abstract: Key Points Question Is neoadjuvant endocrine therapy (NET) an alternative treatment for neoadjuvant chemotherapy (NACT) in patients with invasive ductal carcinoma (IDC) of the breast who have strong hormone receptor (HR) positivity and human epidermal… read more here.
Keywords: endocrine therapy; hormone receptor; invasive ductal; ductal carcinoma ... See more keywords
Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.10331
Abstract: Key Points Question What factors are associated with surgery preference (wide local excision vs mastectomy) among a prospective cohort of women with newly diagnosed ductal carcinoma in situ (DCIS) before and after magnetic resonance imaging… read more here.
Keywords: magnetic resonance; surgery preference; ductal carcinoma; resonance imaging ... See more keywords
Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30425
Abstract: The National Surgical Adjuvant Breast and Bowel Project B35 and International Breast Cancer Intervention Studies II Ductal Carcinoma In Situ trials showed similar treatment effects of anastrozole and tamoxifen in reducing cancer recurrence risk among… read more here.
Keywords: ductal carcinoma; initiation; carcinoma situ; adherence ... See more keywords
Improving the well‐being of women with ductal carcinoma in situ: A worthy goal with an unclear route to success
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34125
Abstract: Approximately 50,000 women are diagnosed with ductal carcinoma in situ (DCIS) in the United States each year. The prognostic significance of DCIS has been called into question, as small studies have shown that anywhere from… read more here.
Keywords: ductal carcinoma; carcinoma situ; treatment; cancer ... See more keywords
The heparan sulphate proteoglycan Syndecan‐1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast
Sign Up to like & getrecommendations! Published in 2022 at "IUBMB Life"
DOI: 10.1002/iub.2623
Abstract: Ductal carcinoma in situ (DCIS) is a form of breast cancer that is restricted to the lactiferous ducts and has not yet invaded the surrounding breast tissue. Dysregulation of the transmembrane heparan sulphate proteoglycan Syndecan‐1… read more here.
Keywords: ductal carcinoma; sdc; breast; progression ... See more keywords
Stiffness Could be a Predictor of AJCC Prognostic Stage Groups in Preoperative Invasive Ductal Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Ultrasound in Medicine"
DOI: 10.1002/jum.15657
Abstract: This study aimed to evaluate the stiffness of 2‐dimensional (2D) shear wave elastography (SWE) in preoperatively predicting the prognostic stage groups of invasive ductal carcinoma (IDC). read more here.
Keywords: prognostic stage; stage groups; ductal carcinoma; invasive ductal ... See more keywords
Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast
Sign Up to like & getrecommendations! Published in 2021 at "Virchows Archiv"
DOI: 10.1007/s00428-021-03040-6
Abstract: Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic abnormalities, and potential for progression. Molecular heterogeneity has been extensively studied in DCIS. Yet… read more here.
Keywords: carcinoma situ; heterogeneity; dcis; morphological intratumor ... See more keywords
Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013
Sign Up to like & getrecommendations! Published in 2017 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-017-4436-9
Abstract: PurposeBreast-conserving surgery (BCS) followed by radiotherapy (RT) with or without endocrine therapy (ET) is a standard treatment option for ductal carcinoma in situ (DCIS). We sought to investigate national patterns in the use of adjuvant… read more here.
Keywords: 2004 2013; use; dcis; conserving surgery ... See more keywords
Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes
Sign Up to like & getrecommendations! Published in 2020 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-020-06014-5
Abstract: To use the National Cancer Database to assess treatment patterns in very young women with ductal carcinoma in situ (DCIS) given their propensity for higher risk features and increased risk of recurrence. We used the… read more here.
Keywords: endocrine therapy; adjuvant endocrine; treatment; group ... See more keywords
Influence of rurality on lymph node assessment among women diagnosed with ductal carcinoma in situ and treated with mastectomy, SEER 2000–2015
Sign Up to like & getrecommendations! Published in 2022 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-021-06495-y
Abstract: Despite recommendations from national organizations supporting the use of lymph node assessment (LNA) among patients with ductal carcinoma in situ (DCIS) at time of mastectomy, variation in practice patterns across the United States has been… read more here.
Keywords: lymph; rurality; carcinoma situ; lymph node ... See more keywords
Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches
Sign Up to like & getrecommendations! Published in 2018 at "Metabolomics"
DOI: 10.1007/s11306-018-1405-1
Abstract: IntroductionInvasive ductal carcinoma (IDC) is a type of breast cancer, usually detected in advanced stages due to its asymptomatic nature which ultimately leads to low survival rate. Identification of urinary metabolic adaptations induced by IDC… read more here.
Keywords: urinary metabolomic; untargeted approaches; analysis; ductal carcinoma ... See more keywords